Show simple item record

Clinical Remission in Severe Asthma : A Pooled Post hoc Analysis of the Patient Journey with Benralizumab

dc.contributor.authorMenzies-Gow, Andrew
dc.contributor.authorHoyte, Flavia L.
dc.contributor.authorPrice, David
dc.contributor.authorCohen, David
dc.contributor.authorBarker, Peter
dc.contributor.authorKreindler, James
dc.contributor.authorJison, Maria
dc.contributor.authorBrooks, Christopher L.
dc.contributor.authorPapeleu, Peggy
dc.contributor.authorKatial, Rohit
dc.date.accessioned2022-05-05T09:19:01Z
dc.date.available2022-05-05T09:19:01Z
dc.date.issued2022-05-01
dc.identifier.citationMenzies-Gow , A , Hoyte , F L , Price , D , Cohen , D , Barker , P , Kreindler , J , Jison , M , Brooks , C L , Papeleu , P & Katial , R 2022 , ' Clinical Remission in Severe Asthma : A Pooled Post hoc Analysis of the Patient Journey with Benralizumab ' , Advances in Therapy , vol. 39 , pp. 2065–2084 . https://doi.org/10.1007/s12325-022-02098-1en
dc.identifier.issn0741-238X
dc.identifier.otherPURE: 214150052
dc.identifier.otherPURE UUID: 12da78b4-96d2-4771-ac5c-2ef3e3efba56
dc.identifier.otherScopus: 85126230183
dc.identifier.urihttps://hdl.handle.net/2164/18523
dc.descriptionFunding This study, the Rapid Service Fee, and the Open Access Fee were funded by AstraZeneca (Gaithersburg, MD, USA).en
dc.format.extent20
dc.language.isoeng
dc.relation.ispartofAdvances in Therapyen
dc.rightsThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.en
dc.subjectBenralizumaben
dc.subjectBiologic therapiesen
dc.subjectOral corticosteroids (OCS)en
dc.subjectPrecision medicineen
dc.subjectRemissionen
dc.subjectSevere eosinophilic asthmaen
dc.subjectSuper-responseen
dc.subjectTreat-to-targeten
dc.subjectR Medicineen
dc.subjectSupplementary Informationen
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleClinical Remission in Severe Asthma : A Pooled Post hoc Analysis of the Patient Journey with Benralizumaben
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1007/s12325-022-02098-1
dc.identifier.vol39en


Files in this item

Thumbnail
Name:
Menzies_Gow_etal_AT_Clinical_R ...
Size:
1.387Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record